IRONWOOD PHARMACEUTICALS, INC. Purchase Commitment, Remaining Minimum Amount Committed
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Purchase Commitment, Remaining Minimum Amount Committed of $3.20 million as of 2015-06-30, per its 10-Q filed 2015-08-07.
Discontinued › Notes › Commitment and Contingencies
us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted · last filed 2015-08-07
- 2015-06-30: Purchase Commitment, Remaining Minimum Amount Committed $3.20M.
| Period end | Purchase Commitment, Remaining Minimum Amount Committed |
|---|---|
| 2015-06-30 | $3.20M 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |